REFERENCES

1. Virani SS, Alonso A, Benjamin EJ, et al. On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2020 update: a report from the American Heart Association. Circulation 2020;141:e139-596.

2. Sabik JF, Lytle BW, Blackstone EH, Houghtaling PL, Cosgrove DM. Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg 2005;79:544-51.

3. Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, Lespérance J. Long-term fate of bypass grafts: the coronary artery surgery study (CASS) and montreal heart institute experiences. Circulation 1985;72:V71-8.

4. Favaloro RG. Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique. J Thorac Cardiovasc Surg 1969;58:178-85.

5. Schwann TA, Habib RH, Wallace A, et al. Operative outcomes of multiple-arterial versus single-arterial coronary bypass grafting. Ann Thorac Surg 2018;105:1109-19.

6. Mckavanagh P, Yanagawa B, Zawadowski G, Cheema A. Management and prevention of saphenous vein graft failure: a review. Cardiol Ther 2017;6:203-23.

7. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1-6.

8. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper G, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-26.

9. Gaudino M, Benedetto U, Fremes S, et al. Association of radial artery graft vs saphenous vein graft with long-term cardiovascular outcomes among patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis. JAMA 2020;324:179-87.

10. Locker C, Schaff HV, Dearani JA, et al. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease. Circulation 2012;126:1023-30.

11. Takagi H, Goto S, Watanabe T, Mizuno Y, Kawai N, Umemoto T. A meta-analysis of adjusted hazard ratios from 20 observational studies of bilateral versus single internal thoracic artery coronary artery bypass grafting. J Thorac Cardiovasc Surg 2014;148:1282-90.

12. Lytle BW, Loop FD, Taylor PC, et al. Vein graft disease: the clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg 1992;103:831-40.

13. Halabi AR, Alexander JH, Shaw LK, et al. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol 2005;96:1254-9.

14. Lopes RD, Mehta RH, Hafley GE, et al. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation 2012;125:749-56.

15. Violaris AG, Newby AC, Angelini GD. Effects of external stenting on wall thickening in arteriovenous bypass grafts. Ann Thorac Surg 1993;55:667-71.

16. Zwolak RM, Adams MC, Clowes AW. Kinetics of vein graft hyperplasia: association with tangential stress. J Vasc Surg 198;5:126-36.

17. Kohler TR, Kirkman TR, Clowes AW. The effect of rigid external support on vein graft adaptation to the arterial circulation. J Vasc Surg 1989;9:277-85.

18. Izzat MB, Mehta D, Bryan AJ, Reeves B, Newby AC, Angelini GD. Influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting. Circulation 1996;94:1741-5.

19. Mehta D, George SJ, Jeremy JY, et al. External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med 1998;4:235-9.

20. Parsonnet V, Lari AA, Shah IH. New stent for support of veins in arterial grafts. Arch Surg 1963;87:696-702.

21. Liao SW, Lu X, Putnam AJ, Kassab GS. A novel time-varying poly lactic-co glycolic acid external sheath for vein grafts designed under physiological loading. Tissue Eng 2007;13:2855-62.

22. Jeremy JY, Bulbulia R, Johnson JL, et al. A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening. J Thorac Cardiovasc Surg 2004;127:1766-72.

23. Vijayan V, Shukla N, Johnson JL, et al. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J Vasc Surg 2004;40:1011-9.

24. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 1985;5:293-302.

25. Lee SW, Antiga L, Steinman DA. Correlations among indicators of disturbed flow at the normal carotid bifurcation. J Biomech Eng 2009;131:061013.

26. Meirson T, Orion E, Avrahami I. Numerical analysis of venous external scaffolding technology for saphenous vein grafts. J Biomech 2015;48:2090-5.

27. Meirson T, Orion E, Di Mario C, et al. Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia. J Thorac Cardiovasc Surg 2015;150:871-9.

28. Amin S, Werner RS, Madsen PL, Krasopoulos G, Taggart DP. Influence of external stenting on venous graft flow parameters in coronary artery bypass grafting: a randomized study. Interact Cardiovasc Thorac Surg 2018;26:926-31.

29. Ramachandra AB, Sankaran S, Humphrey JD, Marsden AL. Computational simulation of the adaptive capacity of vein grafts in response to increased pressure. J Biomech Eng 2015;137:031009.

30. Ramachandra AB, Humphrey JD, Marsden AL. Gradual loading ameliorates maladaptation in computational simulations of vein graft growth and remodelling. J R Soc Interface 2017;14:20160995.

31. Ramachandra AB, Wang H, Wnorowski A, et al. Biodegradable external wrapping promotes favorable adaptation in an ovine vein graft model. Acta Biomater 2022;151:414-25.

32. Longchamp A, Alonso F, Dubuis C, et al. The use of external mesh reinforcement to reduce intimal hyperplasia and preserve the structure of human saphenous veins. Biomaterials 2014;35:2588-99.

33. Ben-gal Y, Taggart DP, Williams MR, et al. Expandable external support device to improve Saphenous Vein Graft Patency after CABG. J Cardiothorac Surg 2013;8:122.

34. Sato A, Kawamoto S, Watanabe M, et al. A novel biodegradable external mesh stent improved long-term patency of vein grafts by inhibiting intimal–medial hyperplasia in an experimental canine model. Gen Thorac Cardiovasc Surg 2016;64:1-9.

35. El-kurdi MS, Hong Y, Stankus JJ, Soletti L, Wagner WR, Vorp DA. Transient elastic support for vein grafts using a constricting microfibrillar polymer wrap. Biomaterials 2008;29:3213-20.

36. El-kurdi M, Soletti L, Mcgrath J, et al. Functional remodeling of an electrospun polydimethylsiloxane-based polyether urethane external vein graft support device in an ovine model. J Biomed Mater Res 2019;107:2135-49.

37. Yasuda S, Goda M, Shibuya T, et al. An appropriately sized soft polyester external stent prevents enlargement and neointimal hyperplasia of a saphenous vein graft in a canine model. Artif Organs 2019;43:577-83.

38. Abbasi K, Shalileh K, Anvari MS, et al. Perivascular nitric oxide delivery to saphenous vein grafts prevents graft stenosis after coronary artery bypass grafting: a novel sheep model. Cardiology 2011;118:8-15.

39. Handa M, Li W, Morioka K, Takamori A, Yamada N, Ihaya A. Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft. J Vasc Surg 2008;48:1566-74.

40. Nishio H, Masumoto H, Sakamoto K, Yamazaki K, Ikeda T, Minatoya K. MicroRNA-145-loaded poly(lactic-co-glycolic acid) nanoparticles attenuate venous intimal hyperplasia in a rabbit model. J Thorac Cardiovasc Surg 2019;157:2242-51.

41. Kahraman N, Yumun G, Gücü A, et al. Administration of perivascular cyanoacrylate for the prevention of cellular damage in saphenous vein grafts: an experimental model. Cardiovasc J Afr 2016;27:159-63.

42. Dai L, Gao M, Gu C, Zhang F, Yu Y. Perivenous application of cyanoacrylate tissue sealants reduces intimal and medial thickening of the vein graft and inflammatory responses in a rabbit model of carotid artery bypass grafting. Eur J Cardiothorac Surg 2016;49:675-81.

43. Bahcivan M, Yucel S, Kefeli M, Gol MK, Can B, Keceligil HT. Inhibition of vein graft intimal hyperplasia by periadventitial application of hyaluronic acid-carboxymethyl cellulose: an experimental study. Scand Cardiovasc J 2008;42:161-5.

44. Salinas HM, Khan SI, Mccormack MC, et al. Prevention of vein graft intimal hyperplasia with photochemical tissue passivation. J Vasc Surg 2017;65:190-6.

45. Alexander JH, Hafley G, Harrington RA, et al. PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 2005;294:2446-54.

46. Lopes RD, Williams JB, Mehta RH, et al. Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of ex-vivo vein graft ENgineering via transfection IV (PREVENT IV) 5-year results. Am Heart J 2012;164:379-86.e1.

47. Murphy GJ, Newby AC, Jeremy JY, Baumbach A, Angelini GD. A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the extent study. J Thorac Cardiovasc Surg 2007;134:504-5.

48. Schoettler J, Jussli-melchers J, Grothusen C, et al. Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively. Interact Cardiovasc Thorac Surg 2011;13:396-400.

49. Inderbitzin DT, Bremerich J, Matt P, Grapow MT, Eckstein FS, Reuthebuch O. One-year patency control and risk analysis of eSVS®-mesh-supported coronary saphenous vein grafts. J Cardiothorac Surg 2015;10:108.

50. Taggart DP, Ben Gal Y, Lees B, et al. A randomized trial of external stenting for saphenous vein grafts in coronary artery bypass grafting. Ann Thorac Surg 2015;99:2039-45.

51. Taggart DP, Amin S, Djordjevic J, et al. A prospective study of external stenting of saphenous vein grafts to the right coronary artery: the VEST II study. Eur J Cardiothorac Surg 2017;51:952-8.

52. Taggart DP, Webb CM, Desouza A, et al. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial. J Cardiothorac Surg 2018;13:117.

53. Taggart DP, Gavrilov Y, Krasopoulos G, et al. External stenting and disease progression in saphenous vein grafts two years after coronary artery bypass grafting: a multicenter randomized trial. J Thorac Cardiovasc Surg 2022;164:1532-41.e2.

54. Icahn School of Medicine at Mount Sinai. A multi-center, randomized, within-subject-controlled, open label study of the safety and effectiveness of vest, venous external support. (VEST Pivotal). Identifier: NCT03209609. Available from: https://clinicaltrials.gov/study/NCT03209609 [Last accessed on 13 Dec 2023].